Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TROP2-PET and 18F-FDG PET to Predict Efficacy of Anti TROP2 ADC in Advanced Breast Cancer
NCT07471776Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Mar 2026
- Primary completion
- Mar 2028
- Modality
- Nanobodies (VHH)
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga-TROP2 in breast cancer, sponsored by Fudan University. Started Mar 2026; status: recruiting.
02
Drugs
68Ga-TROP2
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07471776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07471776.